US Stock MarketDetailed Quotes
CLVLY CLINUVEL PHARMACEUTICALS LTD SPON ADR EA REP 1 ORD NPV
- 7.490
- -0.010-0.13%
15min DelayClose Dec 20 16:00 ET
374.95MMarket Cap17.22P/E (TTM)
7.910High7.490Low3.32KVolume7.910Open7.500Pre Close24.96KTurnover0.01%Turnover Ratio17.22P/E (Static)50.06MShares11.38952wk High2.91P/B374.95MFloat Cap7.46052wk Low0.03Dividend TTM50.06MShs Float31.176Historical High0.44%Div YieldTTM5.60%Amplitude7.460Historical Low7.527Avg Price1Lot Size
About CLINUVEL PHARMACEUTICALS LTD SPON ADR EA REP 1 ORD NPV Company
Clinuvel Pharmaceuticals Ltd. operates as a biopharmaceutical company. The firm engages in the development of SCENESSE, its proprietary photoprotective drug. It also offers drugs for the treatment of various skin disorders. The company was founded by Robert Thomas Dorr on December 14, 1999 and is headquartered in Melbourne, Australia.
Company Profile
SymbolCLVLY
Company NameCLINUVEL PHARMACEUTICALS LTD SPON ADR EA REP 1 ORD NPV
Founded1999
CEODr. Philippe J. Wolgen, M.B.A.,M.D.
MarketPink Market
Employees16
Fiscal Year Ends06-30
Address535 Bourke Street,Level 11
CityMelbourne
ProvinceVictoria (VIC)
CountryAustralia
Zip Code3000
Phone61-3-9660-4900
Websitehttp://www.clinuvel.com
Company Executives
- Name
- Position
- Salary
- Dr. Philippe J. Wolgen, M.B.A.,M.D.
- Director, Managing Director and Chief Executive Officer
- --
- Dr. Karen Agersborg
- Independent Director
- --
- Professor Jeffrey Rosenfeld
- Independent Director
- --
- Susan Smith
- Independent Director
- --
- Brenda M. Shanahan
- Independent Director
- --
Heat List
US
Overall
Symbol
Price
% Chg
No Data